Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04128202 · ClinicalTrials.gov registry record · NA
Online Intervention to Prevent Perinatal Depression and Promote Breastfeeding
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04128202 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 22 participants.
The verdict
NCT04128202, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
"SunnysidePlus" will functionally integrate a web based intervention targeting skills to promote and support breastfeeding, manage mood,and prevent depression. Sunnyside Plus will build upon the previously tested "Sunnyside" intervention which targeted skills to manage mood through an interactive website with didactic material and tools. Women in weeks 20-28 of their pregnancy will be randomized to receive either Sunnyside Plus or Sunnyside. The Sunnyside intervention will consist of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum. Sunnyside Plus will include additional education and support to improve breastfeeding outcomes. Breastfeeding education and skills will be provided during the 6 weeks of online lessons during pregnancy. Breastfeeding support will continue through 6 weeks postpartum. This postpartum support will involve weekly online lessons, text support, and video support calls with a Lactation Educator provided on an as-needed basis. SunnysidePlus has the potential to provide a novel paradigm for improving breastfeeding outcomes and preventing depression; one that is accessible, highly scalable and cost-effective.
Interventions
- BEHAVIORAL Sunnyside
- BEHAVIORAL Sunnyside Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2021-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04128202
The ClinicalTrials.gov registry entry for NCT04128202 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sunnyside is the first listed.
NCT04128202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04128202 about?
NCT04128202 is a clinical study titled "Online Intervention to Prevent Perinatal Depression and Promote Breastfeeding". "SunnysidePlus" will functionally integrate a web based intervention targeting skills to promote and support breastfeeding, manage mood,and prevent depression. Sunnyside Plus will build upon the previously tested "Sunnyside" intervention which targeted skills to manage mood through an interactive we...
What is the current status of trial NCT04128202?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-06-15. Estimated completion is 2021-07-15.
What interventions are being tested in trial NCT04128202?
The interventions under investigation include: Sunnyside (BEHAVIORAL), Sunnyside Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT04128202?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.